To check the effectiveness of vamana karma(panchakarma) and maharasnadi kwatha in PCOS condition

To evaluate the combined effect of Vamana karma and Maharasnadi kwatha in Polycystic ovarian syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031444

Enrollment

Registered

2021-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: VAMANA KARMA ,MAHARASNADI KWATHA: VAMANA KARMA MAHARASNADI KWATHA 25ML BD FOR 2 MONTHS Intervention2: Vamana karma: Deepana pachana with chitrakadi vati 2 TID for 3 days followed by mu

Eligibility

Inclusion criteria

Inclusion criteria: POLYCYSTIC OVARIAN SYNDROME IS DEFINED AS PRESENCE OF ANY 2 OF THE FOLLOWING SUCH AS 1.MENSTRUALIRREGULARITY(OLIGOMENORRHOEA/AMENORRHOEA) 2.HYPERANDROGENISM 3.POLYCYSTIC OVARIES VISUALISED THROUGH USG

Exclusion criteria

Exclusion criteria: SUBJECTS HAVING 1. DIABETES MELLITUS, HYPERTENSION,THYROID DYSFUNCTIONS 2.HYPERPROLACTINEMIA 3.GROSS STRUCTURAL ABNORMALITIES OF REPRODUCTIVE ORGANS 4.BENIGN OR MALIGNANT TUMORS OF REPRODUCTIVE ORGANS 5. SUBJECTS HAVING HIV VDRL AND HbsAg

Design outcomes

Primary

Measure	Time frame
Regularity of the menstrual cycle , Reduction in ovarian volume and reduction in cyst sizeTimepoint: After 3 months	—

Secondary

Measure	Time frame
REDUCTION IN HIRSUTISM ACNE ACANTHOSIS NIGRICANS BMITimepoint: 90 DAYS	—

Countries

India

Contacts

Public ContactDr Sushmitha S Hadimane

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan

drprathima.jain@gmail.com9611990497

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026